9,628 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Sheaff Brock Investment Advisors LLC

Sheaff Brock Investment Advisors LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 9,628 shares of the company's stock, valued at approximately $514,000.

Several other institutional investors also recently bought and sold shares of DOCS. UMB Bank n.a. increased its holdings in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc acquired a new stake in shares of Doximity during the 3rd quarter worth $46,000. Covestor Ltd boosted its position in Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after purchasing an additional 1,370 shares during the period. Finally, First Horizon Advisors Inc. boosted its position in Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after purchasing an additional 384 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 37.40% of the stock is owned by company insiders.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded down $1.58 during trading hours on Thursday, hitting $75.10. The stock had a trading volume of 2,583,597 shares, compared to its average volume of 2,395,807. The stock's fifty day simple moving average is $59.34 and its 200 day simple moving average is $48.55. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The firm has a market capitalization of $14.02 billion, a price-to-earnings ratio of 75.10, a PEG ratio of 4.26 and a beta of 1.39.

Analyst Upgrades and Downgrades

DOCS has been the subject of a number of research reports. Canaccord Genuity Group cut shares of Doximity from a "buy" rating to a "hold" rating and upped their price target for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. KeyCorp decreased their price objective on shares of Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Wednesday, January 8th. Barclays upped their price objective on shares of Doximity from $52.00 to $75.00 and gave the company an "overweight" rating in a research report on Monday, November 11th. Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Finally, Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and increased their price target for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Doximity presently has an average rating of "Moderate Buy" and an average price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.